D-420-2013 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-420-2013 was initiated by Novartis Consumer Health on Apr 19, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 3,828 Tubes.

Recall details

Product Type
Drugs
Report Date
May 29, 2013
Initiation Date
Apr 19, 2013
Termination Date
Nov 4, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,828 Tubes

Product description

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

Distribution pattern

Nationwide

Code information

Lot #: 10118124, Exp: Sept 2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-420-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-420-2013. Report a data issue: hello@regdatalab.com.